# Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells

> **NCT04869397** · PHASE2 · TERMINATED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 19 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Allogeneic Wharton's jelly-MSCs (WJ-MSC)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04869397
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-14
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-05-26
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** DSMB advised discontinuing the study prematurely because recruitment goals were not achieved.
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869397, "Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04869397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*